Arun Duggal
Jubilant Pharma @ Jubilant Pharma
New Delhi, India
Arun Duggal is a Series A investor at Jubilant Pharma in New Delhi focused on Recruiting and Human Resources. Arun Duggal (68), joined the ITC Board as an Independent Director on September 15, 2014.Duggal, a Mechanical Engineer from the Indian Institute of Technology, Delhi, and an MBA from the Indian Institute of Management (IIM), Ahmedabad, is an international banker with global experience in financial strategy, M&A and capital raising. Hisprofessional career includes 26 years with Bank of America (BoA), primarily in the USA, Hong Kong and Japan, with his last assignment as Chief Executive with BoA, India, from 1998 to 2001. He was the Chief Financial Officer of HCL Technologies Limited, India, from 2001 to 2003. He has also been the Chairman of the American Chamber of Commerce, India, and on the Board of Governors of the National Institute of Bank Management. Duggal is presently Chairman of FICCI's Centre for Corporate Governance, a visiting faculty at IIM, Ahmedabad, and a Senior Advisor, Asia Pacific for Transparency International, Berlin. He is involved in several initiatives in social and educational sectors.Duggal is the Chairman of ICRA Limited and International Asset & Reconstruction Company. He is also Director on the Boards of Dish TV India Limited, Adani Ports and Special Economic Zone Limited and Sanlam Limited, South Africa, among others.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arun Duggal invests in
Stages Arun Duggal invests in
Countries Arun Duggal invests in
Investment Focus
Industry
- Recruiting 1 (100%)
- Human Resources 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Round One
|
Round One allows jobseekers to buy a guaranteed interview with employees in the firm of their choice. Please visit http://www.roundone.in for more details. | $1M / Series A / Mar 20, 2015 |
About Jubilant Pharma
Jubilant Pharma Limited is a company committed to providing solutions to the pharmaceuticals industry across the value chain. It is a subsidiary of Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company.The Company provides solutions to global pharmaceutical customers, offering a wide range of products &services. Jubilant Pharma , is engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile and Non-sterile products through six USFDA approved manufacturing facilities in India, USA and Canada.The Company’s success is an outcome of extensive research and development in the pharmaceutical space, which enabled it to move up the pharmaceutical value chain for products and services across geographies. Jubilant has been constantly investing in various growth platforms thereby promoting a culture of innovation.At Jubilant Pharma, it is constant endeavours to improve the products and processes, to elevate the quality of production and cost competitiveness and to build value for its customers.The Company has amplified the business by building capabilities internally, through strategic expansions and acquisitions, thereby, developing network of world class manufacturing facilities in India (two) and in North America (four). Headquartered in Singapore it has a dedicated team of around 4300 people across the globe and has extended its reach globally with ground presence in India, North America and Europe.Jubilant Pharma’s progress in diverse businesses is a result of extensive R&D. Innovation at Jubilant is backed by strong chemistry, bio science expertise and the panoptic knowledge acquired over the years. The Company has strengths in R&D through a strong scientific team, modern facilities, command over affordable technologies and economies of scale into a synergistic organic entity, thereby, continuously developing and nurturing high quality products and technologies.In line with Jubilant’s persistent focus on sustainability of business, it strives to improve stakeholder value through improved eco-efficient use of capital and natural resources. In the Company’s approach to sustainable development, the stress is laid on the triple bottom line of - Economics, Environment and Social performance. Jubilant Pharma has also pledged towards working on various areas for energy conservation and climate change mitigation.
Jubilant Pharma Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Arun Duggal
Jubilant Pharma
|
|||
Giuliano Perfetti
CEO
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Arun Duggal invest in?
Arun Duggal invests primarily in Recruiting and Human Resources startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Arun Duggal last invest?
The most recent investment recorded for Arun Duggal closed in Mar 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
